Omid Harandi

Omid Harandi is an accomplished expert in cell therapy, currently serving as Vice President and Head of Cell Therapy at SalioGen Therapeutics since February 2022, and as a Biotechnology and Technology Advisory Board Member at Penn State University since October 2022. Harandi's extensive experience includes consulting for early-stage platforms in the biotech, medicine, and healthcare sectors since March 2020, and previous leadership roles at Flagship Pioneering Labs and Rubius Therapeutics, where significant advancements in cell and gene therapy, RNA designs, and non-viral gene delivery systems were achieved. Educational credentials include a Ph.D. in Genetics from Penn State University, a postdoctoral fellowship focused on stem cell/microRNA pathways from UMass Chan Medical School, and a research fellowship in hematology/oncology from Harvard Medical School.